Results
1 -
10 of
11Adenosine A2A Receptor Antagonists in L-DOPA-Induced Motor Fluctuations, The Adenosinergic System Symptomatic and Neuroprotective Effects of A2A Receptor Antagonists in Parkinson?s Disease, Adenosine Adenosine A2A Receptor Antagonists, Novel Therapeutic Approaches to the Treatment of Parkinson?s Disease Adenosinergic Receptor Antagonists: Clinical Experience in Parkinson?s Disease, The Adenosinergic System Adenosine A2A Receptor Antagonists in Drug Development, The Adenosinergic System Adenosine A2A Antagonists in Parkinsonu2019s Disease: Whatu2019s Next?, Current Neurology and Neuroscience Reports Selektiver Adenosin-A2A-Rezeptor-Antagonist reduziert die Wirkfluktuationen, InFo Neurologie & Psychiatrie Adenosine A2A Receptor Antagonists in Parkinsonu2019s Disease: Progress in Clinical Trials from the Newly Approved Istradefylline to Drugs in Early Development and Those Already Discontinued, CNS Drugs Bessere Lebensqualit??t bei M. Parkinson als Ziel, DNP - Der Neurologe und Psychiater